{
  "report_rows": [
    {
      "kpi": "Revenue",
      "prediction": "IN-LINE",
      "answer": "pred ~$806M vs. cons $804M",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Adjusted EPS",
      "prediction": "BEAT",
      "answer": "pred ~$1.97 vs. cons $1.94",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Organic constant-currency revenue growth",
      "prediction": "BEAT",
      "answer": "pred ~5.3% vs. cons 5.0%",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "FY2026 revenue guidance midpoint",
      "prediction": "LOWER",
      "answer": "guide ~$3.215B vs. cons $3.230B (FY2026; prior range reaffirmed)",
      "confidence": "HIGH"
    },
    {
      "kpi": "FY2026 adjusted EBITDA guidance midpoint",
      "prediction": "LOWER",
      "answer": "guide ~$1.810B vs. cons $1.820B (FY2026; prior range reaffirmed)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY2026 adjusted EPS guidance midpoint",
      "prediction": "LOWER",
      "answer": "guide ~$7.60 vs. cons $7.65 (FY2026; prior range reaffirmed)",
      "confidence": "HIGH"
    },
    {
      "kpi": "Second-half organic constant-currency revenue growth commentary",
      "prediction": "LOWER",
      "answer": "guide ~6.8% vs. cons 7.1% (2H2026)",
      "confidence": "LOW"
    }
  ],
  "day1_residual_pct": 1.8,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": 0.6,
  "day5_path": "FADE",
  "day5_rationale": "An adjusted EPS beat of ~$1.97 vs. $1.94 and OCC growth of ~5.3% vs. 5.0% support the initial move, but an unchanged FY2026 EPS midpoint of ~$7.60 vs. consensus $7.65 implies limited out-period upside and modest estimate cuts after the print.",
  "day5_confidence": "MEDIUM"
}